Clinical Trial Update: Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study assessing RAD001 (everolimus) in combination with radiotherapy for non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• RAD001 (everolimus)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Non-small Cell Lung Cancer, Locally Advanced Disease | Phase 1 | Status: COMPLETED